• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    AngioDynamics, Inc. - Common Stock (NQ: ANGO )

    8.890 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about AngioDynamics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
    From AngioDynamics, Inc.
    Via Business Wire
    Insiders Buying Zumiez And 3 Other Stocks
    Although U.S. stocks closed little changed on Monday, there were a few notable insider trades. 
    Via Benzinga
    Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
    FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees... 
    Via Benzinga
    Exposures Product Safety
    Earnings Preview For AngioDynamics
    Via Benzinga
    ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
    ANGO stock results show that AngioDynamics missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning! 
    Via InvestorPlace
    AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
    From AngioDynamics, Inc.
    Via Business Wire
    Earnings Scheduled For April 4, 2024
    Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. 
    Via Benzinga
    AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
    AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. 
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
    From AngioDynamics, Inc.
    Via Business Wire
    Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
    While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities. 
    Via InvestorPlace
    AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
    The medical device maker's shares have seen an increase of 1.49% over the last month, not keeping up with the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07%. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
    From AngioDynamics, Inc.
    Via Business Wire
    Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know
    Via Benzinga
    Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Why AngioDynamics Stock Got Destroyed Today
    The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected. 
    Via The Motley Fool
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Applied Therapeutics, Inc. 
    Via Benzinga
    ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024
    ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?
    AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of 
    Via Benzinga
    US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition
    Important metrics to track include the flow of individuals entering the labor force and the ratio of part-time workers to full-timers. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
    From AngioDynamics, Inc.
    Via Business Wire
    Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive Day
    The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, with the index moving to the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, with the Nasdaq... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday
    With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
    Via Benzinga
    Earnings Scheduled For January 5, 2024
    Companies Reporting Before The Bell • Constellation Brands (NYSE:STZ) is estimated to report quarterly earnings at $3.00 per share on revenue of $2.54 billion. 
    Via Benzinga
    AngioDynamics to Present at the J.P. Morgan Healthcare Conference
    From AngioDynamics, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.